Back to results
US 2022/0010273 A1Published application
Use of lactoferrin for generating myeloid-derived suppressor cells
AssigneeThe Wistar Institute of Anatomy and Biology
InventorDmitry I. Gabrilovich
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of generating MDSCs ex vivo. The methods include culturing blood cells with lactoferrin.
Claims20
A method of generating MDSCs ex vivo, the method comprising culturing blood cells with lactoferrin.
A method of treating an inflammatory condition comprising administering lactoferrin to a subject in need thereof.
Dependencies are inferred from the claim text.